Dr. Himabundu Endo Crynologist growth and puberty disorders in children, neonatal and childhood hypoglycaemia, Disorders of Sexual Development (DSD), Gender Identity Development, childhood Obesity, metabolic bone disease, late effects of childhood cancer, Type 1 & 2 diabetes in children, pituitary conditions, adolescent gynaecology and transition endocrinology specifically aimed at adolescents with hormone problems.

Dr Bindu has an active interest in medical student, undergraduate and post graduate teaching. She has been an instructor in Msc child health modules and resuscitation courses.


MBBS, DCH, MRCPCH,CCT (Paediatric Endocrinology, Diabetes and General Paediatrics), MPhil (University Of Manchester).

Work Experience

Dr Bindu has worked as a tertiary Paediatric & Adolescent Endocrinologist at Leads Teaching Hospitals, UK. she has an expert in the managment of endocrin condition in babies, children & adolescents

Awards & Achievements

  • MPhil ( University of Manchester ) for Clinical & Laboratory Research in Congenital Hyper insulinism. 
  • Awarded the 2009 Sir Peter Tizard Bursary from British Paediatric Surveillance unit to undertake a 13 month study to identify important aspects of autoimmune Addison’s disease in the paediatric population in the UK.
  • Best CME Case presentation in BSPED
  • Dr. Bindu has designed & implemented several path ways to ensure optimal management of childhood & neonatal hypoglycaemia.
  • Dr. Bindu has been the clinical lead for adolescent endocrinology. She strived to provide age appropriate care for teenagers with endocrine conditions. 
  • Feeding Problems Are Persistent in Children with Severe Congenital Hyperinsulinism. Banerjee I, et al. Front Endocrinol (Lausanne). 2016
  • Increased plasma incretin concentrations identifies a subset of patients with persistent congenital hyperinsulinism without KATP channel gene defects. Shi Y, et al. J Pediatr. 2015
  • Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPA(R.). Skae M, et al. Front Endocrinol (Lausanne). 2014
  • Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism. Avatapalle HB, et al. Front Endocrinol (Lausanne). 2013 

Research & Publications

  • Feeding Problems Are Persistent in Children with Severe Congenital Hyperinsulinism. Indraneel Banerjee, Lynette Forsythe, Mars Skae, Hima Bindu Avatapalle, Lindsey Rigby, Louise E. Bowden, Ross Craigie, Raja Padidela, Sarah Ehtisham, Leena Patel, Karen E. Cosgrove, Mark J. Dunne,and Peter E. Clayton. Frontiers in Endocrinology. 2016; 7: 8.
  • Reduced glycaemic variability in diazoxide-responsive children with congenital hyperinsulinism using supplemental omega-3-polyunsaturated fatty acids; a pilot trial with MaxEPAR . M Skae, H B Avatapalle, I Banerjee, L Rigby, A Vail, P Foster, C Charalambous, L Bowden, R Padidela, L Patel, S Ehtisham, K E Cosgrove, M J Dunne, P E Clayton. Frontiers in Endocrinology  2014; 5: 31.
  • Abnormal Neurodevelopmental Outcomes are Common in Children with transient Congenital Hyperinsulinism. Avatapalle HB, Banerjee I, Shah S, Pryce M, Nicholson J, Rigby L, Caine L, Didi M, Skae M, Ehtisham S, Patel L, Padidela R, Cosgrove KE, Dunne MJ, Clayton PE. Front Endocrinol (Lausanne). 2013 May 20;4:60.

Certifications & Professional Memberships

  • Royal College of Paediatrics and Child Health 
  • British Society of Paediatric Endocrinology and Diabetes (BSPED )
  • European Society of Paediatric Endocrinology